Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
237M
-
Number of holders
-
357
-
Total 13F shares, excl. options
-
218M
-
Shares change
-
+7.42M
-
Total reported value, excl. options
-
$3.2B
-
Value change
-
+$70.8M
-
Put/Call ratio
-
0.62
-
Number of buys
-
159
-
Number of sells
-
-226
-
Price
-
$14.66
Significant Holders of ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) as of Q3 2025
443 filings reported holding ADMA - ADMA BIOLOGICS, INC. - COMMON STOCK as of Q3 2025.
ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) has 357 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 218M shares
of 237M outstanding shares and own 92.09% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (35.6M shares), VANGUARD GROUP INC (21M shares), STATE STREET CORP (13.6M shares), Invesco Ltd. (12.5M shares), Sachem Head Capital Management LP (8.96M shares), GEODE CAPITAL MANAGEMENT, LLC (5.81M shares), Nuveen, LLC (5.72M shares), WESTFIELD CAPITAL MANAGEMENT CO LP (5.11M shares), DIMENSIONAL FUND ADVISORS LP (4.8M shares), and AMERICAN CENTURY COMPANIES INC (4.7M shares).
This table shows the top 357 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.